Author:
Ashar Bimal H.,Miller Redonda G.,Pichard Carmen P.,Levine Rachel,Wright Scott M.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health(social science)
Reference28 articles.
1. Dietary Supplement Health and Education Act of 1994. Public Law 103-417. Available at: http://www.fda.gov/opacom/laws/dshea.html . Accessed March 1, 2007.
2. U.S. Food and Drug Administration. Overview of dietary supplements. Available at: http://www.cfsan.fda.gov/~dms/supplmnt.html . Accessed March 1, 2007.
3. Palmer, M. E., Haller, C., McKinney, P. E., Klein-Schwartz, W., Tschirgi, A., Smolinske, S. C., Woolf, A., Sprague, B. M., Ko, R., Everson, G., Nelson, L. S., Dodd-Butera, T., Bartlett, W. D., & Landzberg, B. R. (2003). Adverse events associated with dietary supplements: An observational study. Lancet, 361, 101–106.
4. Favreau, J. T., Ryu, M. L., Braunstein, G., Orshansky, G., Park, S. S., Coody, G. L., Love, L. A., & Fong, T. L. (2002). Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Annals of Internal Medicine, 136, 590–595.
5. Haller, C. A., & Benowitz, N. L. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. The New England Journal of Medicine, 343, 1833–1838.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献